The Effect of the Use of Computer Game- "My Diabetic Friend" in Children With Type 1 Diabetes

May 4, 2014 updated by: Rabin Medical Center

Randomized Controlled Trial to Evaluate the Effect of 3 Months Use With Interactive Computer Game- "My Diabetic Friend"-Comparing to Conventional Diabetes Education on Metabolic Control, Quality of Life and Diabetes Knowledge in Children With Type 1 Diabetes.

A randomized controlled study to evaluate the effect of 3 months use with interactive computer game- "My Diabetic Friend"- comparing to conventional diabetes education on metabolic control, quality of life and diabetes knowledge.Patients will be randomized into two groups- one group will be supplied with interactive computer game, "My Diabetic friend", installed on a computer designed for children's educational needs for a period of three months and the other group will be supplied with the same computer without the interactive computer game for three months. Metabolic control, quality of life and diabetes knowledge will be evaluated before and after the use of the computer.

The trial is consisting of two main periods: 3 months of the main study period and an optional extension period consisting of the following 3 months :

The study will include two main periods;

  1. Period 1 which will last 3 months, in a randomized controlled manner, this period will serve as the main study period to assess the primary and secondary endpoints of the study.
  2. Period 2: this extension period will not be an integral part of the study, and only patients who are willing will take part at this period, will continue to participate at the optional extension period. During the extension period, patients in the intervention group will be offered to continue the use of the Computer game -"My diabetic friend) for the following 3 months, and patients who participated at the control group during period 1, will be offered to start to use the Computer Game - "My Diabetic Friend" for the following 3 months.

Study Overview

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Petach- Tikva, Israel
        • Schneider Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

7 years to 11 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Type 1 diabetes diagnosed at least one year prior to study entry.
  2. Age:7-11 years old.
  3. Treatment either with CSII or MDI.
  4. HbA1c>8.0%
  5. Signing an informed consent form.

Exclusion Criteria:

  1. Any significant disease or conditions, including psychiatric disorders that in the opinion of the investigator are likely to affect subject compliance or subject's ability to complete the study.
  2. Inability to understand/ complete the questionnaires.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: interactive computer game
Participants will be using the interactive computer game- "My Diabetic Friend", installed on Intel-powered convertible classmate PC.
Participants will use the interactive computer game installed on a convertible PC
Active Comparator: Convertible PC
Participants will be using the convertible classmate PC without the interactive computer game
Participants will be using the convertible PC without the interactive computer game

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of life
Time Frame: After 12 weeks (end of study)
Quality of life questionnaires will be completed
After 12 weeks (end of study)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Metabolic control
Time Frame: After 12 weeks (end of study)
HbA1c will be measured
After 12 weeks (end of study)
Diabetes knowledge
Time Frame: After 12 weeks
Diabetes knowledge questionnaires will be completed
After 12 weeks
Patient's gaming duration
Time Frame: After 12 weeks
The frequency and the duration of use of the interactive computer game by each participant will be monitored by the study team
After 12 weeks
Compliance to diabetes treatment
Time Frame: After 12 weeks
Patient's parents will undergo clinical interview about patient's diabetes adherence
After 12 weeks
Average glucose levels
Time Frame: After 12 weeks (end of study)
After 12 weeks (end of study)
Average number of blood glucose measurements
Time Frame: After 12 weeks (end of study)
After 12 weeks (end of study)
Measurements within normal range
Time Frame: After 12 weeks (end of study)
After 12 weeks (end of study)
Hypoglycemia events
Time Frame: After 12 weeks (end of study)
After 12 weeks (end of study)
Hyperglycemia events
Time Frame: After 12 weeks (end of study)
After 12 weeks (end of study)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2012

Primary Completion (Actual)

August 1, 2013

Study Completion (Actual)

August 1, 2013

Study Registration Dates

First Submitted

May 16, 2012

First Submitted That Met QC Criteria

May 16, 2012

First Posted (Estimate)

May 17, 2012

Study Record Updates

Last Update Posted (Estimate)

May 6, 2014

Last Update Submitted That Met QC Criteria

May 4, 2014

Last Verified

May 1, 2014

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Type 1 Diabetes

Clinical Trials on Interactive computer game

3
Subscribe